Evidence map›Paper›PMID 30254737›Full record

ReviewF1000Research2018

Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation.

Natalie Nevárez, Luis de Lecea

Abstract readReview
In one paragraph

Review in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Self-reported view on work capacity predicts abnormal Oxford Sleep Resistance Test results in patients with obstructive sleep apnea.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Observational
  15. Review
  16. Targeting presynaptic H3 heteroreceptor in nucleus accumbens to improve anxiety and obsessive-compulsive-like behaviors.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  17. Review
  18. Hypocretin (Orexin) Replacement Therapies.Medicine in drug discovery · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Natalie NevárezDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California, USA.ORCID 0000-0002-1664-0585
Luis de LeceaDepartment of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California, USA.

Funding

Optogenetic Control of Vigilance State TransitionR01MH087592 · NIMH · STANFORD UNIVERSITY · PI DE LECEA, LUIS · 2010 to 2017
$3.2M
Optogenetic interrogation of sleep circuits during agingR01AG047671 · NIA · STANFORD UNIVERSITY · PI DE LECEA, LUIS, WYSS-CORAY, TONY · 2014 to 2018
$2.1M
Neuronal mapping of anxiety and panicR01MH102638 · NIMH · STANFORD UNIVERSITY · PI DE LECEA, LUIS · 2014 to 2018
$2.0M
NIA NIH HHS R01 AG047671NIMH NIH HHS R01 MH087592NIMH NIH HHS R01 MH102638
6 · The paper itself

Abstract

The hypocretins (Hcrts) are two alternatively spliced neuropeptides (Hcrt1/Ox-A and Hcrt2/Ox-B) that are synthesized exclusively in the hypothalamus. Data collected in the 20 years since their discovery have supported the view that the Hcrts play a broad role in the control of arousal with a particularly important role in the maintenance of wakefulness and sleep-to-wake transitions. While this latter point has received an overwhelming amount of research attention, a growing literature has begun to broaden our understanding of the many diverse roles that the Hcrts play in physiology and behavior. Here, we review recent advances in the neurobiology of Hcrt in three sections. We begin by surveying findings on Hcrt function within normal sleep/wake states as well as situations of aberrant sleep (that is, narcolepsy). In the second section, we discuss research establishing a role for Hcrt in mood and affect (that is, anxiety, stress, and motivation). Finally, in the third section, we briefly discuss future directions for the field and place an emphasis on analytical modeling of Hcrt neural activity. We hope that the data discussed here provide a broad overview of recent progress in the field and make clear the diversity of roles played by these neuromodulators.

Indexed as

AffectAnimalsHumansHypothalamusMotivationNeurotransmitter AgentsOrexinsSleep Wake DisordersHCRT protein, humanNeurotransmitter AgentsOrexinsaddictionarousalhypothalamusmemorysleepvigilancewake

Identifiers

PMID30254737
PMCPMC6127742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.